Gliacure, Inc
Get Full AccessDescription
- GliaCure is a pioneer in the development of novel therapeutics aimed at treating neurological and neuropsychiatric disorders of the brain. The companys approaches are based on glial targets, a cell type in the brain that has previously been overlooked in drug discovery.The company has developed a small molecule clinical candidate GC021109 for a glial target that has two primary actions downstream of target engagement: the stimulation of phagocytosis and anti-inflammatory actions in which levels of pro-inflammatory cytokines are reduced.GC021109 is currently being developed primarily as a disease modifying treatment of Alzheimers disease; however, its dual phagocytosis and anti-inflammatory actions have the potential to affect other disorders. In addition to its program using GC021109, GliaCure has a pipeline program for the development of therapeutics for astrocytic targets related to additional disorders, such as depression and sleep consolidation.
-
Headquarters: , Middleton, Wisconsin, United States
More -
Phone Number:
-
Website: https://www.gliacure.com
-
Employees:3
-
Revenue:$0 - 1M
-
Legal Name:Gliacure, Inc
-
Gliacure, Inc's Social Media
-
Is this data correct?
-
| NAICS Code: 541611 |
Show More
Frequently Asked Questions regarding Gliacure, Inc
-
What is Gliacure, Inc's official website?
Gliacure, Inc's official website is https://www.gliacure.com
-
What is Gliacure, Inc's Revenue?
Gliacure, Inc's revenue is $0 - 1M
-
What is Gliacure, Inc's NAICS code?
Gliacure, Inc's NAICS code is 541611
-
How many employees are working in Gliacure, Inc
Gliacure, Inc has 3 employees
-
What is Gliacure, Inc's Industry?
Gliacure, Inc is in the industry of Research
-
Who is Gliacure, Inc's Vice President And Co-Founder?
Gliacure, Inc's Vice President And Co-Founder is Mike Szulczewski

